Adam Wieschhaus

Adam Wieschhaus is a Director at Northpond Ventures on the firm’s life science R&D solutions, molecular diagnostics, and environmental sciences teams. Adam is a Board Director at Encodia, Inflammatix, Isolere Bio, IsoPlexis (NASDAQ: ISO), Kytopen, Ori Biotech, Slingshot Biosciences, SpeeDx, Torus Biosystems, Ultivue, and Vestaron. Adam has experience in business and science as he holds a Ph.D. from the University of Illinois College of Medicine, a B.S. in biochemistry and molecular biology from the University of Georgia, and is a CFA charterholder.